iBio amends CEO Martin Brenner's agreement; base salary $522K, bonus target raised to 50% for FY2025

iBio, Inc.

Base salary set at $522,365; FY2025 bonus target increased to 50% of base salary, FY2024 remains 40%.
Severance without cause or for good reason includes 12 months salary, pro-rata bonus, and COBRA coverage.
Upon Sale Event termination: 18 months salary, target bonus, and accelerated vesting of time-vested equity.
Employment is at-will; includes standard termination benefits and non-solicitation/invention assignment clauses.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.